title: Ultrasensitive quantitation of human papillomavirus type 16 E6 oncogene sequences by nested real time PCR.
abstract: BACKGROUND
  We have developed an ultrasensitive method based on conventional PCR preamplification followed by nested amplification through real time PCR (qPCR) in the presence of the DNA intercalating agent EvaGreen.
  
  
  RESULTS
  Amplification mixtures calibrated with a known number of pHV101 copies carrying a 645 base pair (bp)-long insert of the human papillomavirus type 16 (HPV16) E6 oncogene were used to generate the E6-1 amplicon of 645 bp by conventional PCR and then the E6-2 amplicon of 237 bp by nested qPCR. Direct and nested qPCR mixtures for E6-2 amplification corresponding to 2.5 x 102-2.5 x 106 initial pHV101 copies had threshold cycle (Ct) values in the ranges of 18.7-29.0 and 10.0-25.0, respectively. The Ct of qPCR mixtures prepared with 1/50 volumes of preamplified mixtures containing 50 ng of DNA of the SiHa cell line (derived from an invasive cervical cancer with one HPV16 genome per cell) was 19.9. Thermal fluorescence extinction profiles of E6-2 amplicons generated from pHV101 and SiHa DNA were identical, with a peak at 85.5 degrees C.
  
  
  CONCLUSIONS
  Our method based on conventional preamplification for 15 cycles increased 10,750 times the sensitivity of nested qPCR for the quantitation of the E6 viral oncogene and confirmed that the SiHa cell line contains one E6-HPV16 copy per cell.
authors.affiliation: División de Biología Molecular, Instituto Potosino de Investigación Científica y Tecnológica, Camino de la Presa San José 2055, 78216 San Luis Potosí S,L,P,, México. rlopez@ipicyt.edu.mx.
authors.forename: Socorro
authors.initials: S
authors.lastname: Hernández-Arteaga
authors.forename: Rubén
authors.initials: R
authors.lastname: López-Revilla
references.citation: N Engl J Med. 2007 Oct 18;357(16):1579-88
references.pmid: 17942871
references.citation: Proc Soc Exp Biol Med. 1970 Nov;135(2):543-5
references.pmid: 5529598
references.citation: N Engl J Med. 2003 Feb 6;348(6):518-27
references.pmid: 12571259
references.citation: Arch Pathol Lab Med. 2003 Aug;127(8):940-5
references.pmid: 12873165
references.citation: J Clin Microbiol. 2004 Jul;42(7):3176-84
references.pmid: 15243079
references.citation: Salud Publica Mex. 2003;45 Suppl 3:S326-39
references.pmid: 14746025
references.citation: J Pathol. 1999 Sep;189(1):12-9
references.pmid: 10451482
references.citation: Biotechniques. 2004 Feb;36(2):214-6
references.pmid: 14989083
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):477-84
references.pmid: 12814990
references.citation: Urol Res. 1998;26(3):165-9
references.pmid: 9694597
references.citation: Anal Biochem. 2008 Sep 1;380(1):131-3
references.pmid: 18539127
references.citation: Infect Agent Cancer. 2008 Feb 28;3:3
references.pmid: 18307798